Sharekhan

Albert David Ltd

Fri 22/05/2026,15:56:32 | NSE : ALBERTDAVD

₹ 705.80-0.50 (-0.07%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 714.65

Previous Close

₹ 706.30

Volume

5455

Mkt Cap ( Rs. Cr)

₹402.81

High

₹ 715.00

Low

₹ 704.90

52 Week High

₹ 957.50

52 Week Low

₹ 579.90

Book Value Per Share

₹ 716.99

Dividend Yield

0.71

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Albert David Ltd

Your Vote -

Buy

81.82%

Hold

9.09%

Sell

9.09%

81.82%

22 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

705.80

6

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

6

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Albert David Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Albert David - Updates

    14 May 2026, 5:56PM Albert David Limited has informed the Exchange regarding 'Financial results for the period ended 31-Mar-2026 in Machine Readable Form'.
  • Albert David - Integrated Filing- Financial

    13 May 2026, 4:00PM Integrated filing financials for the fourth quarter and financial year ended 31st March 2026
  • Albert David - Copy of Newspaper Publication

    13 May 2026, 1:11PM Albert David Limited has informed the Exchange about Copy of Newspaper Publication
  • Albert David - Integrated Filing Financials For The Fourth Quarter And Year Ended 31St March 2026

    13 May 2026, 4:37PM Integrated Filing Financials for the fourth quarter and year ended 31st March 2026
  • Albert David - KMP's Authorised To Determine Materiality Under Regulation 30(5) Of SEBI(LODR),2015

    12 May 2026, 8:24PM Regulation 30(5) of SEBI ( LODR), 2015 KMP'S authorised to determine materiality under Regulation 30(5) of SEBI (LODR), 2015
  • Albert David - General Updates

    12 May 2026, 8:20PM Albert David Limited has informed the Exchange about Book Closure Dates for 87th AGM
  • Albert David - Book Closure Date - The Register Of Members And Share Transfer Books Of The Company Shall Remain Closed From F

    12 May 2026, 8:16PM Book closure date
  • Albert David - Record Date Fixed On 30Th July 2026 For The Purpose Of Final Dividend And Determining Members Eligible To Vote

    12 May 2026, 8:12PM Record date fixed on 30th July 2026 for the purpose of final dividend and determining members eligible to vote for 87th AGM.
  • Albert David - Record Date

    12 May 2026, 8:12PM Albert David Limited has informed the Exchange that Record date for the purpose of Dividend & 87th AGM Meeting is 30-Jul-2026.
  • Albert David - General Updates

    12 May 2026, 8:03PM Albert David Limited has informed the Exchange about General Updates about KMP'S authorised to determine Materiality under Regulation 30(5) of SEBI(LO
  • Albert David - Change in Management

    12 May 2026, 7:45PM Albert David Limited has informed the Exchange about change in Management by appointment of Mr. Amit Mahla as the Chief Executive officer w.e.f 12.05.
  • Albert David - General Updates

    12 May 2026, 7:31PM Albert David Limited has informed the Exchange about Re-appointment of M/s. S. Gupta & Co., Cost and Management Accountant, as the Cost Auditorsof the
  • Albert David - Corporate Action-Board approves Dividend

    12 May 2026, 7:29PM Board approves final dividend at Rs. 5.00 for the F.Y. 2025-26
  • Albert David - General Updates

    12 May 2026, 7:28PM Albert David Limited has informed the Exchange about Re-appointment of PricewaterhouseCoopersServices LLP as Internal Auditors for F.Y. 2026-27
  • Albert David - Outcome of Board Meeting

    12 May 2026, 7:20PM Albert David Limited has informed the Exchange regarding Outcome of Board Meeting held on May 12, 2026.
  • Albert David - Dividend

    12 May 2026, 7:14PM Albert David Limited has informed the Exchange that Board of Directors at its meeting held on May 12, 2026, recommended Final Dividend of Rs. 5 per eq
  • Albert David - Re-Appointment Of Cost Auditors For The F.Y. 2026-27

    12 May 2026, 7:10PM Re-appointment of Cost Auditors for the F.Y. 2026-27
  • Albert David - Outcome of Board Meeting

    12 May 2026, 7:10PM Albert David Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Albert David - Re-Appointment Of Internal Auditors For The F.Y. 2026-27

    12 May 2026, 7:05PM Re-appointment of Internal Auditors for the F.Y. 2026-27
  • Albert David posts Q4 net loss of Rs 21.43 cr

    12 May 2026, 7:00PM The company reported standalone net loss during the quarter stood at Rs 21.43 crore as compared to net loss of Rs 10.33 crore in the previous year qua
  • Albert David - Announcement under Regulation 30 (LODR)-Change in Management

    12 May 2026, 6:52PM Change in Management
  • Albert David - Results- Financial Results For The Fourth Quarter And Year Ended 31St March, 2026

    12 May 2026, 6:47PM Financial Results for the Fourth quarter and year ended 31st March, 2026
  • Albert David - Board Meeting Outcome for Outcome Of Board Meeting Dated 12Th May, 2026

    12 May 2026, 6:30PM Outcome of Board Meeting dated 12th May, 2026 to consider and approve Intimation of Board Meeting to consider and approve the Audited Financial Result
  • Albert David - KMP's Authorised To Determine Materiality Under Regulation 30(5) Of SEBI(LODR),2015

    12 May 2026, 8:24PM Regulation 30(5) of SEBI ( LODR), 2015 KMP'S authorised to determine materiality under Regulation 30(5) of SEBI (LODR), 2015
  • Albert David - KMP's Authorised To Determine Materiality Under Regulation 30(5) Of SEBI(LODR),2015

    12 May 2026, 8:24PM Regulation 30(5) of SEBI ( LODR), 2015 KMP'S authorised to determine materiality under Regulation 30(5) of SEBI (LODR), 2015
  • Albert David - Board Meeting Intimation for Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations

    4 May 2026, 3:27PM Albert David Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and ap
  • Albert David has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    20 Apr 2026, 6:10PM As of March 2026, 62.23% is owned by Indian Promoters and 37.76% by Public. <p align=justify> Institutional holds 2.23% (Insurance Companies 1.61%) an
  • Albert David - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Apr 2026, 12:41PM Albert David Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Albert David - Disclosure under SEBI Takeover Regulations

    7 Apr 2026, 11:20AM Arun Kumar Kothari has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantia
  • Albert David - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Apr 2026, 12:24PM Submission of Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
  • Albert David - Trading Window

    23 Mar 2026, 5:58PM Albert David Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201
  • Albert David - Copy of Newspaper Publication

    13 Mar 2026, 4:30PM Albert David Limited has informed the Exchange about Copy of Newspaper Publication
  • Albert David - Copy of Newspaper Publication

    11 Mar 2026, 3:33PM Albert David Limited has informed the Exchange about Copy of Newspaper Publication
  • Albert David - Cessation

    10 Mar 2026, 5:21PM Albert David Limited has informed the Exchange regarding Cessation of Thakkar Rushabh Kishorbhai as International Business Leader of the company w.e.f
  • Albert David - Announcement under Regulation 30 (LODR)-Change in Management

    10 Mar 2026, 4:12PM Resignation of Senior Managerial Personnel (Change in Management)

Key fundamentals

Evaluate the intrinsic value of Albert David Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 420.0139 402.5326 385.0809 315.5417 283.2368
Liabilities 420.0139 402.5326 385.0809 315.5417 283.2368
Equity 5.7072 5.7072 5.7072 5.7072 5.7072
Gross Profit 5.4666 3.0263 46.8796 44.3433 40.7942
Net Profit -1.4947 17.2008 75.4201 36.1749 35.2583
Cash From Operating Activities -7.6585 -28.4358 45.5022 10.515 40.3647
NPM(%) -0.44 4.97 20.8 10.59 11.24
Revenue 333.5981 345.768 362.4617 341.5644 313.5114
Expenses 328.1315 342.7417 315.5821 297.2211 272.7172
ROE(%) -0.36 4.2 18.43 8.84 8.61

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
5 50 0.71 781.1
25 Jul 2025 5 50 0.71 884
02 Aug 2024 11.5 115 0.71 1201.95
03 Aug 2023 9 90 0.71 596.4
01 Aug 2022 9 90 0.71 545.85
06 Sep 2021 6 60 0.71 513.4
13 Mar 2020 7 70 0.71 411.35
01 Aug 2019 6 60 0.71 490.55
24 Aug 2018 5.5 55 0.71 388
01 Sep 2017 5.5 55 0.71 316.55

Peers

Other companies within the same industry or sector that are comparable to Albert David Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Lotus Eye Hospital and Institute Ltd 109.19 1.26 352.23 1461.77 3.55 0.00
Vaishali Pharma Ltd 7.00 0.14 0.00 9170.18 3.13 0.00
Astec Lifesciences Ltd 771.80 4.77 0.00 1378.48 -363.15 0.00
Suraksha Diagnostic Ltd 313.20 -2.16 50.68 3660.77 309.01 0.00

Company Info

The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.

The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.

Parent Organisation

Albert David Ltd.

Founded

16/11/1938

Managing Director

Mr.Umesh Manohar Kunte

NSE Symbol

ALBERTDAVDEQ

FAQ

OPEN FREE* DEMAT ACCOUNT